- thehindubusinessline.com
- Posted On 07 November 2026
FDA investigates tumour risk linked to Novartis’ Zolgensma gene therapy
The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated with Novartis?...
Source:
thehindubusinessline.com